Filing Flows › Microvision (MVIS) › Q3 2026 › vs Q3 2025
Microvision (MVIS) Q3 2026 vs Q3 2025 (year over year)
Microvision's revenue rose $2.2M (+896%) from $241K in Q3 2025 to $2.4M in Q3 2026. The biggest changes: Product Revenue +$2.2M (80×); License and Royalty Revenue −$201K (-94%).
Microvision, Q3 2026: revenue $2.4M (+896% year over year), operating margin -889.0%, net loss $12.2M, operating cash flow −$13.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product Revenue | $2.2M | $28K | $2.2M | 80× |
| License and Royalty Revenue | $12K | $213K | −$201K | -94% |
| Revenue | $2.4M | $241K | $2.2M | +896% |
| Other income, net | $9.1M | −$1.3M | $10.5M | — |
| Net loss | $12.2M | $14.2M | −$2.0M | -14% |
| Costs & expenses | $23.8M | $14.5M | $9.3M | +64% |
| Operating costs | $23.7M | $13.0M | $10.8M | +83% |
| Income tax | $33K | $172K | −$139K | -81% |
| Cost of revenue | $1.2M | $957K | $244K | +25% |
| Research & development | $13.2M | $8.0M | $5.2M | +65% |
| SG&A | $9.4M | $4.0M | $5.3M | +132% |
| Operating cash sources | $17.7M | $17.9M | −$155K | -0.9% |
| Depreciation & amortization | $2.9M | $1.4M | $1.5M | +110% |
| Share-based compensation | $1.2M | $0 | $1.2M | — |
| Cash used in operations | $13.6M | $16.5M | −$2.9M | -17% |
| Net loss absorbed | $12.2M | $14.2M | −$2.0M | -14% |
| Working capital & other | $5.5M | $3.7M | $1.8M | +50% |
Questions
How much did Microvision's revenue grow year over year in Q3 2026?
Microvision's revenue rose $2.2M (+896%) from $241K in Q3 2025 to $2.4M in Q3 2026.
What drove Microvision's revenue change in Q3 2026?
Product Revenue +$2.2M (80×); License and Royalty Revenue −$201K (-94%).